The Division of Rheumatology endeavors to improve the lives of patients suffering from rheumatic diseases through innovative, patient-centered research. Staff members are involved in all phases of research, from basic investigations using animal models of human disease to clinical investigations translating new testing or treatments to patients.

Basic research in the division includes humanized models of rheumatoid arthritis and systemic lupus erythematosus as well as investigation of disease pathogenesis using biospecimens from patients with rheumatoid arthritis, systemic lupus erythematosus, inflammatory myositis and vasculitis.

Clinical research studies are currently under way to determine the rates, predictors, costs and outcomes of a variety of rheumatic diseases. A number of clinical trials are under way testing both established drugs and novel experimental therapies. Key areas of interest include:

  • Rheumatoid arthritis
  • Juvenile idiopathic arthritis
  • Psoriatic arthritis
  • Gout
  • Systemic lupus erythematosus
  • Sjogren's syndrome
  • Adult and pediatric myositis
  • Polymyalgia rheumatica
  • Giant cell arteritis
  • Takayasu arteritis

The ultimate goal of research programs in the division is to develop personalized treatment strategies that improve the health of patients with rheumatic diseases.